macrophage activation syndrome (MAS)
Macrophage Activation Syndrome (also known as Hemophagocytic lymphohistiocytosis (HLH)
- when associated with rheumatic disorders, is a frequently fatal complication of infections, rheumatic disorders, and hematopoietic malignancies
- often termed a “cytokine storm,” MAS occurs among the rheumatic diseases most typically in Still's disease but also in systemic lupus erythematosus and Kawasaki disease (2)
- can also accompany infection, malignancy, and inborn errors of immunity (2)
- is a life-threatening condition that is usually diagnosed among febrile hospitalized patients (children and adults) who commonly present with unremitting fever and a shock-like multiorgan dysfunction scenario
- laboratory studies reveal:
- pancytopenia
- elevated liver enzymes
- elevated markers of inflammation (ESR, CRP)
- hyperferritinemia,
- features of coagulopathy
- in about 60% of cases, excess hemophagocytosis (macrophages/histiocytes engulfing other hematopoietic cell types) is noted on biopsy specimens from the bone marrow, liver, lymph nodes, and other organs (1)
Reference:
- Eloseily EM, Cron RQ. Macrophage Activation Syndrome. The Microbiome in Rheumatic Diseases and Infection. 2018 Mar 13:151–82.
- Nigrovic, PA. Macrophage Activation Syndrome. Arthritis Rheumatol 2025; 77: 367-379
Create an account to add page annotations
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page